1. Introduction {#sec1}
===============

Fungal infection in humans is increasing; *Candida* species are the most frequently reported organisms. Approximately 95% of all invasive *Candida* infections are caused by five species: *Candida albicans*, *Candida glabrata*, *Candida parapsilosis*, *Candida tropicalis,* and *Candida krusei* [@bib1]. Among the *Candida* species, *C. albicans* is the most prevalent in both healthy patients and those with infection [@bib2; @bib3]. Recently, the four non-*C. albicans* species were found to be more frequently isolated in humans than *C. albicans* [@bib4]. *C. glabrata* was the second most common non-*C. albicans* species in fungemia in the United States and also most commonly recovered from the oral cavities of patients with human immunodeficiency virus [@bib5]. The increase in the number of *C. glabrata* systemic infections is cause for concern because the high mortality rate associated with *C. glabrata* fungemia [@bib6]. Because fungal infections are increasing, the use of antifungal agents has correspondingly increased. In particular, fluconazole is a highly effective antifungal agent used for the treatment of candidiasis. Voriconazole is a triazole derivative of fluconazole, and the activity for *Candida* may be better than that of fluconazole. However, the widespread and prolonged use of fluconazole in recent years has led to the development of drug resistance in *Candida* species [@bib7; @bib8]. In addition, the resistance of *Candida* to fluconazole is highly predictive of resistance to voriconazole agent. The observation of cross-resistance in *C. glabrata* strains receiving fluconazole and voriconazole therapy of *C. glabrata* in patients with candidemia was reported [@bib9]. The resistant mechanisms to azole antifungal agents have been studied in *C. albicans* [@bib10; @bib11; @bib12]. However, *C. glabrata* has an intrinsic resistant tendency to fluconazole, and the molecular basis for the intrinsically low susceptibility of *C. glabrata* remains unclear. Several mechanisms of acquired resistance to the azole antifungal agents have been described in *C. glabrata*. These include upregulation of genes encoding adenosine triphosphate (ATP) binding cassette (ABC) transporters encoded by *CDR1* and *CDR2* [@bib13]. Overexpression of *ERG11*, the gene encoding the target of the azole antifungal agents, has also been associated with acquired azole resistance [@bib14]. Recently, proteomic analysis of azole-susceptible and -resistant *Candida* isolates was accomplished to understand the mechanisms underlying azole antifungal resistance [@bib12; @bib15]. Proteomic analysis has also been used to study the adaptive response of *C. albicans* to fluconazole and itraconazole [@bib16]. Currently, no proteomic analysis exists for voriconazole resistant *C. glabrata* strain. So, we analyzed the expression of proteins of voriconazole-susceptible, susceptible dose-dependent (S-DD), and resistant strains to investigate proteins associated with voriconazole resistance.

2. Materials and methods {#sec2}
========================

2.1. *C. glabrata* strains and growth conditions {#sec2.1}
------------------------------------------------

A total of 56 *C. glabrata* strains collected from tertiary and nontertiary hospitals were used in this study. We previously reported the results of an antifungal susceptibility test [@bib17]. We selected three *C. glabrata* strains according to voriconazole susceptibility for a comparative proteomic study. All strains were stored at --80 °C, and prior to the experiment each strain was subcultured twice on sabouraud dextrose agar to ensure viability and purity. For the proteomic experiment, an aliquot of glycerol stock from each strain was diluted in yeast peptone dextrose (YPD; 1% yeast extract, 2% peptone, 1% dextrose) and grown overnight at 30 °C in a shaking incubator. The cultures were diluted to an optical density 0.2 at OD~600~ in 0.5 L of YPD and grown to the exponential phase of growth.

2.2. Cellular protein extraction {#sec2.2}
--------------------------------

To isolate the cellular proteins, *C. glabrata* cells were cultured in YPD broth at 30 °C to the exponential phase of growth. Cells were harvested in centrifugation 4000 rpm for 15 minutes. The pellet cells were pooled and washed twice using 50 mM Tris-HCl pH 7.6 buffer solution. The cells were disrupted using 0.45-μm glass beads (Sigma, St. Louis, MO, USA) on ice. After homogenization, the solution was centrifuged twice at 14,000 rpm for 20 minutes. The supernatant was harvested carefully without contaminant similar to a lipid component, and it was freeze dried for further experiment.

2.3. Membrane protein extraction {#sec2.3}
--------------------------------

After an exponential phase of growth, cells were harvested, washed with distilled water, and resuspended in homogenizing buffer (50 mM Tris-HCl, pH 7.5, 2 mM EDTA, 1 mM phenylmethylsulfonylfluoride). After disruption of the cell using the glass bead, cell debris and unbroken cells were removed by centrifugation at 5000 *g* for 10 minutes. A crude membrane fraction was isolated from the cell-free supernatant by second centrifugation at 30,000 *g* for 30 minutes. The pellet was washed in GTE buffer (10 mM Tris-HCl, pH 7.0, 0.5 mM EDTA, 20% glucose), resuspended in GTE buffer, and stored at --80 °C. The protein concentration was determined by a micro-Bradford assay using a protein assay kit II (Bio-Rad, Hercules, CA, USA).

2.4. Sample preparation and 2-Dimentional Gel Electrophoresis {#sec2.4}
-------------------------------------------------------------

The harvested samples were suspended in 0.5 mL of 50 mM Tris buffer containing 7 M urea, 2 M thiourea, 4% \[weight/volume (w/v)\] CHAPS, and 16 μL protease inhibitor cocktail (Roche Molecular Biochemicals, Indianapolis, IN, USA). The lysates were homogenized and centrifuged at 12,000 × *g* for 15 minutes. Fifty units of Benzonase (250 units/μL; Sigma) was added to the mixture and suitably stored at −80 °C until use after quantitation by the Bradford method. For 2-DE analysis, pH 3--10 immobilized pH gradient (IPG) strips (Amersham Biosciences, UK, Ltd) were rehydrated in swelling buffer containing 7 M urea, 2 M thiourea, 0.4% (w/v) Dithiothreitol, and 4% (w/v) CHAPS. The protein lysates (500 μg) were cup-loaded into the rehydrated IPG strips using a Multiphor II apparatus (Amersham Biosciences, UK, Ltd) for a total of 57 kVh. The two-dimensional separation was performed on 8--16% (v/v) linear gradient sodium dodecyl sulfate (SDS)-polyacrylamide gels. Following fixation of the gels for 1 hour in a solution of 40% (v/v) methanol containing 5% (v/v) phosphoric acid, the gels were stained with Colloidal Coomassie Blue G-250 solution for 5 hours. The gels were destained in 1% (v/v) acetic acid for 4 hours and then imaged using a GS-710 imaging calibrated densitometer (Bio-Rad).

Protein spot detection and two-dimensional pattern matching were carried out using ImageMasterTM 2D Platinum software (Amersham Biosciences, UK, Ltd). For comparison of protein spot densities between control and treated samples, more than 20 spots throughout all gels were correspondingly landmarked and normalized. The quantified spots of candidate proteins were compared with the aid of histograms. For ensuring the reproducibility of 2DE experiments, each sample was analyzed in duplicate.

2.5. In-gel protein digestion {#sec2.5}
-----------------------------

Protein bands of interest were excised and digested in-gel with sequencing grade, modified trypsin (Promega, Madison, WI, USA). In brief, each protein spot was excised from the gel, placed in a polypropylene tube, and washed four to five times with 150 μL of 1:1 acetonitrile/25 mM ammonium bicarbonate, pH 7.8. The gel was dried in a Speedvac concentrator, and then rehydrated in 30 μL of 25 mM ammonium bicarbonate, pH 7.8, containing 20 ng of trypsin. After incubation at 37 °C for 20 hours, the liquid was transferred to a new tube. Tryptic peptides remaining in the gel matrix were extracted for 40 min at 30 °C with 20 μL of 50% (v/v) aqueous acetonitrile containing 0.1% (v/v) formic acid. The combined supernatants were evaporated in a Speedvac concentrator and dissolved in 8 μL of 5% (v/v) aqueous acetonitrile solution containing 0.1% (v/v) formic acid for mass spectrometric analysis.

2.6. Identification of proteins by liquid chromatograph/tandem mass spectrometry {#sec2.6}
--------------------------------------------------------------------------------

The resulting tryptic peptides were separated and analyzed using reversed phase capillary high-performance liquid chromatography (HPLC) directly coupled to a Finnigan LCQ ion trap mass spectrometer \[liquid chromatography-tandem mass spectrometry (LC-MS/MS)\]. A 0.1 × 20 mm trapping and a 0.075 × 130 mm resolving column were packed with Vydac 218 MS low trifluoroacetic acid C18 beads (5 μm in size, 300 Å in pore size; Vydac, Hesperia, CA, USA) and placed in-line. Next, the peptides were bound to the trapping column for 10 minutes with 5% (v/v) aqueous acetonitrile containing 0.1% (v/v) formic acid, then the bound peptides were eluted with a 50-minute gradient of 5-80% (v/v) acetonitrile containing 0.1% (v/v) formic acid at a flow rate of 0.2 μL/min. For tandem mass spectrometry, a full mass scan range mode was m/z = 450--2000 Da. After determination of the charge states of an ion on zoom scans, product ion spectra were acquired in MS/MS mode with relative collision energy of 55%. The individual spectra from MS/MS were processed using the TurboSEQUEST software (Thermo Quest, San Jose, CA). The generated peak list files were used to query either the MSDB database or National Center for Biotechnology Information (NCBI) using the MASCOT program (<http://www.matrixscience.com>). Modifications of methionine and cysteine, peptide mass tolerance at 2 Da, MS/MS ion mass tolerance at 0.8 Da, allowance of missed cleavage at 2, and charge states (+1, +2, and +3) were taken into account. Only significant hits as defined by MASCOT probability analysis were initially considered.

3. Results {#sec3}
==========

3.1. Strains {#sec3.1}
------------

Among the *C. glabrata* strains, voriconazole susceptible strain \[*C. glabrata* I-49, minimum inhibitory concentration (MIC) 0.5 μg/mL\], S-DD strain (*C. glabrata* D-54, MIC 2 μg/mL) and resistant strain (*C. glabrata* D-91, MIC 4 μg/mL) were selected. All strains were isolated from blood specimen of patients.

3.2. Expression of intracellular proteins and identification {#sec3.2}
------------------------------------------------------------

The two-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis (2D-SDS PAGE) gels are shown in [Figure 1](#fig1){ref-type="fig"}. The profiling of 459 intracellular proteins was detected in three strains. Of the total proteins, 38 proteins having abundance ratios of twofold or more showed continuous increase of expression from susceptible and S-DD to resistant strain. In addition, 34 proteins were identified by LC-MS/MS ([Table 1](#tbl1){ref-type="table"}). The 15 proteins showing decrease of expression from susceptible and S-DD to resistant strain were also identified. Among the identified proteins, aldehyde dehydrogenase family, serine hydroxymethyltransferase, acetolactate synthase, heat shock protein, pyruvate kinase, potassium efflux protein, isocitrate dehydrogenase, and other proteins showed increased expression. Expression was decreased in proteins such as glycerol-3-phosphate dehydrogenase, ATP synthase, acetyl-coA hydrolase, oxidoreductase, and malate dehydrogenases ([Table 1](#tbl1){ref-type="table"}). Among the proteins for which expression was decreased, phosphoglycerate kinase protein showed the largest decreased expression, at 9.09 times reduction of expression. The identified proteins, classified according to their function, are summarized in [Table 2](#tbl2){ref-type="table"}. The functional category showed that the identified proteins were cell regulation, energy production, carbohydrate transport, amino acid transport, and various metabolism-related proteins.

3.3. Expression of membrane proteins and identification {#sec3.3}
-------------------------------------------------------

A total of 329 membrane proteins were resolved by 2D gel electrophoresis. Of the 17 spots (differential ratio twofold or more) for which expression was increased, 12 proteins were identified. The identified proteins showed enolase, heat shock protein 70, pyruvate kinase, cysteine synthase, pyruvate decarboxylase, pyrophosphate requiring enzyme, regulatory modules in signal transduction, and phosphoglycerate kinase ([Table 3](#tbl3){ref-type="table"}). Among the identified proteins, phosphate requiring enzymes showed the most increased expression (3.66 times). Enolase and phosphoglycerate kinase proteins also showed 2.69 and 2.77 times increased expression, respectively. Thirty-seven spots showed decreased expression in the order of susceptible, S-DD, and resistant strains. Among the 37 spots, 31 proteins were identified. The identified membrane proteins included heat shock protein 70, aldehyde dehydrogenase, nicotinamide adenine dinucleotide phosphate-glutamate dehydrogenase, phosphoglycerate mutase I, glutamine aminotransferase, superoxide dismutase, Stm1 protein, phosphoglycerate kinase, and others. A total of 12 heat shock proteins were observed and heat shock protein 70 was 11. In addition, 9 heat shock protein 70 showed the deceased expression in resistant strain compared to susceptible and S-DD strain. The identified membrane proteins were classified into carbohydrate metabolism, amino acid synthesis, and response to stress-related proteins ([Table 4](#tbl4){ref-type="table"}).

4. Discussion {#sec4}
=============

*C. glabrata* is a major opportunistic fungal pathogen of humans and also part of the gastrointestinal microflora in many healthy human beings [@bib1]. The most effective classes of antifungal agents used to treat *C. glabrata* infections are the azoles agents, specifically fluconazole and voriconazole [@bib9]. However, the occurrence of azole-resistant strains resulted in a difficulty of treatment. Currently, the available information of voriconazole resistance in protein levels is sparse. In this study, we compared the expression changes of proteins using the voriconazole susceptible, S-DD, and resistant strains. The results of proteomic analysis showed the tendency of expression increase (38 proteins) was observed in intracellular fractions of resistant strain compared to membrane fraction of susceptible and S-DD strain (17 proteins). The membrane fraction of resistant strain had the tendency of expression decrease (37 proteins) compared to intracellular fraction of susceptible and S-DD strains (18 proteins). The results indicated that the metabolism process is continuously increased from voriconazole susceptible to S-DD, resistant strain but the biochemical reaction may be decreased in membrane fraction to endure the antifungal stress environment. Among the identified proteins, heat shock protein was observed in various spots of intracellular and membrane fractions. Usually, heat shock protein is known as a stress and response related protein. In this study, the expression increase of heat shock protein in intracellular proteins of voriconazole resistant strain was observed in three spots, but 9 heat shock 70 protein showed decreased expression in membrane proteins. This finding indicated that heat shock protein 70 is related to voriconazole resistance. Among the *C. albicans* triazole resistance mechanisms, the molecular chaperone Hsp90 is known to share a correlation. The Hsp90 protein stabilizes calcineurin, thereby enabling calcineurin-dependent stress responses that are required for triazole tolerance of *Candida* strains [@bib18]. In this study, the heat shock protein identified most often was Hsp70 protein, and 9 Hsp70 proteins showed a decrease of expression in membrane fraction, but the exact mechanism with voriconazole resistance needs more investigation. Among the identified membrane proteins, expression of DnaK and Stml protein was reduced in voriconazole resistant strains compared with S-DD and susceptible strains. These proteins are related to protein posttranslation modification and apoptosis, respectively. There has been little information of voriconazole resistance in *C. glabrata* strain, so the proteomic investigation can be useful information for further study.
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![Cellular and membrane protein spot of *C. glabrata* strains resolved by 2D gel electrophoresis. Spots representing differentially expressed proteins that were identified by LC-Ms/Ms peptide mass fingerprinting. (a) cellular protein spot of voriconazole susceptible strain, (b) cellular protein spot of voriconazole SDD strain, (c) cellular protein spot of fluconazole susceptible strain, (d) membrane protein spot of voriconazole susceptible strain, (e) membrane protein spot of voriconazole SDD strain, (f) membrane protein spot of voriconazole resistant strain.](gr1){#fig1}

###### 

Differentially expressed intracellular proteins (by twofold or more), as identified by liquid chromatography-tandem mass spectrometry between voriconazole susceptible, susceptible dose-dependent, and voriconazole resistant strains

  Spot   Protein                                                                       Molecular mass (Dalton)   pI     Fold change (R/S)[a](#tbl1fna){ref-type="table-fn"}
  ------ ----------------------------------------------------------------------------- ------------------------- ------ -----------------------------------------------------
  25     C1-tetrahydrofolate synthase                                                  102,203                   5.98   3.09
  27     Formyltetrahydrofolate synthetase (FTHFS)                                     102,203                   5.98   2.06
  79     ACO1 aconitate hydratase aconitase                                            85,429                    6.78   2.53
  90     Potassium efflux protein KefA                                                 73,694                    5.41   2.05
  115    Sphingolipid long-chain base sensory protein                                  40,387                    5.54   2.27
  116    TKL1 transketolase                                                            73,704                    6.01   2.50
  127    Heat shock protein 70                                                         112,540                   7.87   3.5
  189                                                                                                                   2.15
  540                                                                                                                   2.13
  154    Acetolactate synthase                                                         73,300                    8.55   2.41
  202    LEU4 2-isopropylmalalate synthase                                             67,290                    5.52   2.51
  218    Acetyl-CoA hydrolase/transferase N-terminal domain                            58,541                    6.16   2.38
  228    Phosphoribosylaminoimidazole carboxylase                                      62,672                    6.95   4.42
  238    Pyruvate kinase                                                               55,563                    6.25   2.66
  263    Pyruvate decarboxylase and related thiamine pyrophosphate-requiring enzymes   61,726                    5.59   3.94
  295    Aldehyde dehydrogenase family                                                 55,937                    5.09   2.03
  304    SES1 seryl-transcription RNA synthetase                                       52,775                    5.8    2.19
  319    Iinosine monophosphate dehydrogenase                                          56,969                    6.69   2.86
  396    Serine hydroxymethyltransferase                                               52,271                    6.74   3.1
  397                                                                                                                   3.6
  411    GDP dissociation inhibitor                                                    50,582                    5.66   3.02
  476    Protein with specific affinity for G4 quadruplex nucleic acids                42,134                    8.61   2.33
  504    Isocitrate dehydrogenase                                                      46,728                    5.23   2.52
  505    spP36046 *Saccharomyces cerevisiae* YKL195w                                   44,592                    4.45   2.78
  507    Chromosome segregation adenosine triphosphatases (ATPases)                    55,271                    8.81   14.1
  535    Malate dehydrogenases (MDH) glycosomal and mitochondrial                      39,024                    6.15   2.42
  550    Cyclophilin_ABH_like                                                          41,620                    5.61   2.2
  560    Aspartate/tyrosine/aromatic aminotransferase                                  45,608                    7.2    2.73
  576    Quinone reductase and related Zn-dependent oxidoreductases                    40,823                    6.01   2.24
  603    Branched-chain aminotransferase                                               41,550                    5.82   2.58
  619    Highly similar to *S. cerevisiae* YBR249c ARO4                                38,617                    6.51   2.24
  636    RPC40 DNA-directed RNA polymerase I                                           37,577                    5.22   2.05
  645    *S. cerevisiae* YGR080w                                                       36,175                    5.02   3.49
  777    Peptidase_S8 (serine proteinase)                                              50,008                    5.75   2.25
  107    Glycerol-3-phosphate dehydrogenase                                            43,961                    5.85   −2.82
  142    TKL1 transketolase                                                            73,704                    6.01   −3.57
  321    F0F1 ATP synthase                                                             58,485                    8.99   −2.46
  454    Effector domain of the CAP family of transcription factors                    44,936                    5.92   −2.14
  570    Acetyl-CoA hydrolase                                                                                           −2.53
  609    Oxidoreductases                                                               46,710                    5.76   −2.4
  613                                                                                                                   −3.75
  615    Malate dehydrogenases glycosomal and mitochondrial                            40,487                    9.18   −2.14
  625    Phosphoglycerate kinase                                                       44,590                    6.37   −8.90
  628    Arginase                                                                      35,061                    5.27   −3.13
  633    Highly similar to spP53252 *S. cerevisiae* YGR086c                            35,129                    4.68   −3.03
  723    Uncharacterized enzymes related to aldose 1-epimerase                         33,397                    5.06   −3.15
  774                                                                                                                   −2.07
  909    Hypothetical protein CAGL0I00616g                                             2,183                     5.37   −9.09
  912    ATP synthase D chain, mitochondrial (ATP5H)                                   19,918                    6.64   −2.73

Expression ration of voriconazole-resistant (R) over voriconazole-susceptible (S) strains. The minus sign (−) indicates decreased protein expression of voriconazole-resistant strains in comparison with voriconazole-susceptible strains.

###### 

Functional classification of identified intracellular proteins from voriconazole susceptible, susceptible dose-dependent, and resistant strains

  Protein                                                       Function
  ------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------
  Cell regulation                                               
   Similar with bacterial potassium efflux protein KefA         Regulate iron balance
   Sphingolipid long chain base sensory protein                 Cell wall, antifungal protection
   Heat shock protein 70, 90, 60                                Stress, protein folding
   SES1 seryl-transcription RNA (tRNA) synthetase               Catalyze the formation of aminoacyl-tRNA
   GDP dissociation inhibitor                                   GTP binding protein regulator
   similar to *Saccharomyces cerevisiae* YKL195w                Promotes retention of newly imported proteins
   Chromosome segregation adenosine triphosphatases (ATPases)   Cell division
   Highly similar to *S. cerevisiae* YGR086c                    Unknown function that are induced on cell stress
   CAP family of transcription factors                          Control transcription of genes
  Carbohydrate transport and metabolism                         
   Pyruvate decarboxylase                                       Related thiamine pyrophosphate-requiring enzymes
   Hexokinase                                                   Phosphorylates a six-carbon sugar, a hexose to a hexose phosphate
  Amino acid transport and metabolism                           
   SAM1 S-adenosylmethionine synthetase                         Catalyzes transfer of the adenosyl group of ATP to the sulfur atom of methionine
  Energy production and conversion                              
   F1 ATP synthase                                              Catalyze the ATP synthesis
   Phosphoglycerate kinase                                      Catalyzes the transfer of the high-energy phosphate group of 1,3-biphosphoglycerate to adenosine diphosphate

###### 

Differentially expressed membrane proteins (by twofold or more), as identified by liquid chromatography-tandem mass spectrometry between voriconazole susceptible, susceptible dose-dependent, and voriconazole resistant strains

  Spot       Protein                                                                            Molecular mass (Dalton)   pI     Fold change (R/S)[a](#tbl3fna){ref-type="table-fn"}
  ---------- ---------------------------------------------------------------------------------- ------------------------- ------ -----------------------------------------------------
  12, 314    Enolase                                                                            46,710                    5.76   2.69, 2.56
  132, 169   Hsp70 protein                                                                      6,635                     5.32   2.18, 2.72
  195, 379   Pyruvate kinase (PK)                                                               54,572                    8.26   2.13, 2.21
  244        Cysteine synthase                                                                  55,388                    5.51   2.34
  255, 291   Pyruvate decarboxylase                                                             61,726                    5.59   2.12, 2.31
  276        Pyrophosphate-requiring enzymes                                                    46,993                    4.46   3.66
  284        WD40 domain adaptor/regulatory modules in signal transduction                      46,504                    4.44   2.34
  457        Phosphoglycerate kinase (PGK)                                                      44,590                    6.37   2.77
  50         Heat shock protein                                                                 80,983                    4.82   −2.43
  119, 149   Hsp70 protein                                                                      69,469                    4.96   −2.43, −4.09
  153, 226                                                                                                                       −2.18, −2.74
  357, 552                                                                                                                       −2.54, −3.88
  138, 174                                                                                                                       −28.0, −2.37
  172                                                                                                                            −3.35
  175        *Saccharomyces cerevisiae* YLR259c Heat shock protein                              60,351                    5.14   −4.77
  229        Hexokinase                                                                         53,772                    5.23   −2.39
  260        Aldehyde dehydrogenase family                                                      56,131                    6.07   −2.11
  292        F1 adenosine triphosphate (ATP) synthase beta subunit, nucleotide-binding domain   54,176                    5.14   −2.68
  298        Nicotinamide adenine dinucleotide phosphate -glutamate dehydrogenase               49,711                    5.58   −3.17
  360        SAM1 S-adenosylmethionine synthetase                                               41,700                    5.10   −2.19
  398        ATPase alpha2,Na/K                                                                 116,305                   5.41   −2.56
  462        N terminal of the Stm1 protein                                                     29,791                    9.65   −6.48
  465        Adenosine kinase (AK)                                                              36,250                    5.23   −2.05
  548        Exo-beta-1,3-glucanase                                                             33,667                    4.41   −2.50
  557        Elongation factor 1 beta (EF1B) guanine nucleotide exchange domain                 22,903                    4.33   −3.57
  560        Predicted epimerase, PhzC/PhzF homolog                                             32,286                    4.98   −2.35
  578        Phosphoglycerate mutase 1                                                          27,468                    5.48   −11.1
  597        Phosphoglycerate kinase                                                            18,458                    7.85   −2.51
  602        Mitochondrial ribosomal protein MRP8                                               24,160                    4.73   −2.12
  616        Ribosome antiassociation factor IF6                                                26,367                    4.52   −2.62
  629        TrpR binding protein WrbA                                                          29,728                    6.54   −2.08
  632        Alcohol dehydrogenase GroES-like domain                                            36,721                    6.21   −2.25
  645        Type 1 glutamine amidotransferase (GATase1)                                        25,479                    5.16   −4.45
  658        Phosphoglycerate kinase (PGK)                                                      44,590                    6.37   −2,15
  715        Chain A, yeast Cu, Zn enzyme superoxide dismutase                                  15,714                    5.63   −7.19

Expression ration of voriconazole-resistant (R) over voriconazole-susceptible (S) strains. The minus sign (−) indicates decreased protein expression of voriconazole-resistant strains in comparison with voriconazole-susceptible strains.

###### 

Functional classification of identified membrane proteins from voriconazole susceptible, susceptible dose-dependent, and resistant strains

  Protein                                                       Function
  ------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------
  Cell regulation                                               
   Similar with bacterial potassium efflux protein KefA         Regulate iron balance
   Sphingolipid long-chain base sensory protein                 Cell wall, antifungal protection
   Heat shock protein 70, 90, 60                                Stress, protein folding
   SES1 seryl-transcription RNA (tRNA) synthetase               Catalyze the formation of aminoacyl-tRNA
   GDP dissociation inhibitor                                   GTP binding protein regulator
   similar to *Saccharomyces cerevisiae* YKL195w                promotes retention of newly imported proteins
   Chromosome segregation adenosine triphosphatases (ATPases)   Cell division
   highly similar to *Saccharomyces cerevisiae*YGR086c          Unknown function that are induced on cell stress
   Cu, Zn enzyme superoxide dismutase                           Catalyse the conversion of superoxide radicals to oxygen
   CAP family of transcription factors                          Control transcription of genes
   Molecular chaperone DnaK                                     Posttranslational modification, protein turnover, chaperones
  Carbohydrate transport and metabolism                         
   Pyruvate decarboxylase                                       Related thiamine pyrophosphate-requiring enzymes
   Hexokinase                                                   Phosphorylates a six-carbon sugar, a hexose to a hexose phosphate
  Amino acid transport and metabolism                           
   SAM1 S-adenosylmethionine synthetase                         Catalyzes transfer of the adenosyl group of ATP to the sulfur atom of methionine
   Elongation factor 1 beta (EF1B)                              catalyzes the exchange of GDP bound to the G-protein, EF1A, for GTP
  Energy production and conversion                              
   F1 ATP synthase                                              Catalyze the ATP synthesis
   Phosphoglycerate kinase                                      catalyzes the transfer of the high-energy phosphate group of 1,3-biphosphoglycerate to adenosine diphosphate
